Carey RM and Siragy HMNewly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev2003; 24: 261-271.
2.
Paul M., Poyan Mehr A. and Kreutz R.Physiology of local renin-angiotensin systems. Physiol Rev2006; 86: 747-803.
3.
Erdös EGAngiotensin I converting enzyme and the changes in our concepts through the years. Hypertension1990; 16: 363-370.
4.
Azizi M., Rousseau A., Ezan E., et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem-cell regulator N-acetyl-seryl-aspartyl-lysylproline . J Clin Invest1996; 97: 839-844.
5.
Gould AB and Green D.Kinetics of the human renin and human substrate reaction. Cardiovasc Res1971; 5: 86-89.
6.
Carey RM, Wang ZQ and Siragy HMRole of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension2000; 35: 155-163.
7.
Urata H., Kinoshita A., Misono KS, Bumpus FM and Husain A.Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem1990 ; 265: 22348-22357.
8.
Okunishi H., Miyazaki M. and Toda N.Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens1984; 2: 277-284.
9.
Burrell LM, Johnston CI, Tikellis C. and Cooper MEACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol Metab2004; 15: 166-169.
10.
de Gasparo M., Catt KJ, Inagami T., Wright JW and Unger T.International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev2000; 52: 415-472.
11.
Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T. and Sraer JDPivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest2002; 109: 1417-1427.
